Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Müller S[au]:

Search results

Items: 1 to 50 of 4431

1.

High-throughput proteomics fiber typing (ProFiT) for comprehensive characterization of single skeletal muscle fibers.

Kallabis S, Abraham L, Müller S, Dzialas V, Türk C, Wiederstein JL, Bock T, Nolte H, Nogara L, Blaauw B, Braun T, Krüger M.

Skelet Muscle. 2020 Mar 23;10:7. doi: 10.1186/s13395-020-00226-5. eCollection 2020.

PMID:
32211148
2.

60/30: 60% of the Morbidity-Associated Multiple Sclerosis Disease Burden Comes From the 30% of Persons With Higher Impairments.

Kaufmann M, Puhan MA, Salmen A, Kamm CP, Manjaly ZM, Calabrese P, Schippling S, Müller S, Kuhle J, Pot C, Gobbi C, Steinemann N, von Wyl V; Swiss Multiple Sclerosis Registry (SMSR).

Front Neurol. 2020 Mar 6;11:156. doi: 10.3389/fneur.2020.00156. eCollection 2020.

PMID:
32210908
3.

Quantifying Target Occupancy of Small Molecules Within Living Cells.

Robers MB, Friedman-Ohana R, Huber K, Kilpatrick L, Vasta JD, Berger BT, Chaudhry C, Hill S, Müller S, Knapp S, Wood KV.

Annu Rev Biochem. 2020 Mar 24. doi: 10.1146/annurev-biochem-011420-092302. [Epub ahead of print]

PMID:
32208767
4.

Fibroblast Growth Factor 2-Mediated Regulation of Neuronal Exosome Release Depends on VAMP3/Cellubrevin in Hippocampal Neurons.

Kumar R, Tang Q, Müller SA, Gao P, Mahlstedt D, Zampagni S, Tan Y, Klingl A, Bötzel K, Lichtenthaler SF, Höglinger GU, Koeglsperger T.

Adv Sci (Weinh). 2020 Jan 28;7(6):1902372. doi: 10.1002/advs.201902372. eCollection 2020 Mar.

5.

A Highly Selective Chemical Probe for Activin Receptor-like Kinases ALK4 and ALK5.

Hanke T, Wong JF, Berger BT, Abdi I, Berger LM, Tesch R, Tredup C, Bullock AN, Müller S, Knapp S.

ACS Chem Biol. 2020 Mar 20. doi: 10.1021/acschembio.0c00076. [Epub ahead of print]

PMID:
32176847
6.

CK2 Inhibition Prior to Status Epilepticus Persistently Enhances KCa2 Function in CA1 Which Slows Down Disease Progression.

Schulze F, Müller S, Guli X, Schumann L, Brehme H, Riffert T, Rohde M, Goerss D, Rackow S, Einsle A, Kirschstein T, Köhling R.

Front Cell Neurosci. 2020 Feb 26;14:33. doi: 10.3389/fncel.2020.00033. eCollection 2020.

7.

Diffusion-weighted MRI in the assessment of nephroblastoma: results of a multi-center trial.

Hötker AM, Lollert A, Mazaheri Y, Müller S, Schenk JP, Mildenberger PC, Akin O, Graf N, Staatz G.

Abdom Radiol (NY). 2020 Mar 12. doi: 10.1007/s00261-020-02475-w. [Epub ahead of print]

PMID:
32166338
8.

Temporal Ordering in Endocytic Clathrin-Coated Vesicle Formation via AP2 Phosphorylation.

Wrobel AG, Kadlecova Z, Kamenicky J, Yang JC, Herrmann T, Kelly BT, McCoy AJ, Evans PR, Martin S, Müller S, Salomon S, Sroubek F, Neuhaus D, Höning S, Owen DJ.

Dev Cell. 2020 Mar 9;52(5):673. doi: 10.1016/j.devcel.2020.02.010. No abstract available.

9.

Functional Biomarkers for the Selenium Status in a Human Nutritional Intervention Study.

Müller SM, Dawczynski C, Wiest J, Lorkowski S, Kipp AP, Schwerdtle T.

Nutrients. 2020 Mar 2;12(3). pii: E676. doi: 10.3390/nu12030676.

10.

[Management of plaque psoriasis in adults].

Müller S, Schultes D, Wilsmann-Theis D.

Hautarzt. 2020 Mar;71(3):227-243. doi: 10.1007/s00105-020-04555-w. German.

PMID:
32130433
11.

Descriptive Evaluation and Accuracy of a Mobile App to Assess Fall Risk in Seniors: Retrospective Case-Control Study.

Rabe S, Azhand A, Pommer W, Müller S, Steinert A.

JMIR Aging. 2020 Feb 14;3(1):e16131. doi: 10.2196/16131.

12.

[The View of a Cost-Efficient Peripheral Dwarf].

Fellenberg TV, Müller S.

Praxis (Bern 1994). 2020;109(3):171-174. doi: 10.1024/1661-8157/a003431. German. No abstract available.

PMID:
32126919
13.
14.

High-Level Expression, Purification and Initial Characterization of Recombinant Arabidopsis Histidine Kinase AHK1.

Hofmann A, Müller S, Drechsler T, Berleth M, Caesar K, Rohr L, Harter K, Groth G.

Plants (Basel). 2020 Mar 1;9(3). pii: E304. doi: 10.3390/plants9030304.

15.

High Cytotoxic Efficiency of Lentivirally and Alpharetrovirally Engineered CD19-Specific Chimeric Antigen Receptor Natural Killer Cells Against Acute Lymphoblastic Leukemia.

Müller S, Bexte T, Gebel V, Kalensee F, Stolzenberg E, Hartmann J, Koehl U, Schambach A, Wels WS, Modlich U, Ullrich E.

Front Immunol. 2020 Jan 24;10:3123. doi: 10.3389/fimmu.2019.03123. eCollection 2019.

16.

Neuro-Clinical signatures of language impairments: A theoretical framework for function-to-structure mapping in clinics.

Kherif F, Muller S.

Curr Top Med Chem. 2020 Mar 1. doi: 10.2174/1568026620666200302111130. [Epub ahead of print]

PMID:
32116193
17.

Implementation of a Talbot-Lau x-ray deflectometer diagnostic platform for the OMEGA EP laser.

Valdivia MP, Stutman D, Stoeckl C, Mileham C, Zou J, Muller S, Kaiser K, Sorce C, Keiter PA, Fein JR, Trantham M, Drake RP, Regan SP.

Rev Sci Instrum. 2020 Feb 1;91(2):023511. doi: 10.1063/1.5123919.

PMID:
32113451
18.

Splitting aptamers and nucleic acid enzymes for the development of advanced biosensors.

Debiais M, Lelievre A, Smietana M, Müller S.

Nucleic Acids Res. 2020 Feb 29. pii: gkaa132. doi: 10.1093/nar/gkaa132. [Epub ahead of print]

PMID:
32112111
19.

The tetraspanin Tspan15 is an essential subunit of an ADAM10 scissor complex.

Koo CZ, Harrison N, Noy PJ, Szyroka J, Matthews AL, Hsia HE, Müller SA, Tüshaus J, Goulding J, Willis K, Apicella C, Cragoe B, Davis E, Keles M, Malinova A, McFarlane TA, Morrison PR, Nguyen HTH, Sykes MC, Ahmed H, Di Maio A, Seipold L, Saftig P, Cull E, Pliotas C, Rubinstein E, Poulter NS, Briddon SJ, Holliday ND, Lichtenthaler SF, Tomlinson MG.

J Biol Chem. 2020 Feb 28. pii: jbc.RA120.012601. doi: 10.1074/jbc.RA120.012601. [Epub ahead of print]

20.

How to Implement Adherence-Promoting Programs in Clinical Practice? A Discrete Choice Experiment on Physicians' Preferences.

Müller S, Ziemssen T, Diehm C, Duncker T, Hoffmanns P, Thate-Waschke IM, Schürks M, Wilke T.

Patient Prefer Adherence. 2020 Feb 14;14:267-276. doi: 10.2147/PPA.S222725. eCollection 2020.

21.
22.

First Clinical Experience with Anti-myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis.

Heckmann J, Todorova M, Müller S, Broser PJ, Sturm V.

Klin Monbl Augenheilkd. 2020 Feb 24. doi: 10.1055/a-1068-2506. [Epub ahead of print]

PMID:
32092775
23.

Novel routes towards bioplastics from plants: Elucidation of the methylperillate biosynthesis pathway from Salvia dorisiana trichomes.

Jongedijk E, Müller S, van Dijk ADJ, Schijlen E, Champagne A, Boutry M, Levisson M, van der Krol S, Bouwmeester H, Beekwilder J.

J Exp Bot. 2020 Feb 24. pii: eraa086. doi: 10.1093/jxb/eraa086. [Epub ahead of print]

PMID:
32090266
24.

Clinical and Biomechanical Outcomes of One-Stage Treatment of a Simultaneous Ipsilateral Patellar Tendon and ACL Tear Combined with a Tibial Plateau Fracture: A Case Study.

Ismailidis P, Kernen R, Egloff C, Nüesch C, Mündermann A, Müller SA.

Case Rep Orthop. 2020 Feb 4;2020:5793948. doi: 10.1155/2020/5793948. eCollection 2020.

25.

Usefulness of Serum Free Thyroxine Concentration to Predict Ventricular Arrhythmia Risk in Euthyroid Patients With Structural Heart Disease.

Müller P, Dietrich JW, Lin T, Bejinariu A, Binnebößel S, Bergen F, Schmidt J, Müller SK, Chatzitomaris A, Kurt M, Gerguri S, Clasen L, Klein HH, Kelm M, Makimoto H.

Am J Cardiol. 2020 Jan 29. pii: S0002-9149(20)30060-6. doi: 10.1016/j.amjcard.2020.01.019. [Epub ahead of print]

PMID:
32087999
26.

Salinomycin Derivatives Kill Breast Cancer Stem Cells via Lysosomal Iron Targeting.

Versini A, Colombeau L, Hienzsch A, Gaillet C, Retailleau P, Debieu S, Müller S, Cañeque T, Rodriguez R.

Chemistry. 2020 Feb 21. doi: 10.1002/chem.202000335. [Epub ahead of print]

PMID:
32083773
27.

DMT1 Inhibitors Kill Cancer Stem Cells by Blocking Lysosomal Iron Translocation.

Turcu AL, Versini A, Khene N, Gaillet C, Cañeque T, Müller S, Rodriguez R.

Chemistry. 2020 Feb 21. doi: 10.1002/chem.202000159. [Epub ahead of print]

PMID:
32083771
28.

Identification of molecular targets for the targeted treatment of gastric cancer using dasatinib.

Montenegro RC, Howarth A, Ceroni A, Fedele V, Farran B, Mesquita FP, Frejno M, Berger BT, Heinzlmeir S, Sailem HZ, Tesch R, Ebner D, Knapp S, Burbano R, Kuster B, Müller S.

Oncotarget. 2020 Feb 4;11(5):535-549. doi: 10.18632/oncotarget.27462. eCollection 2020 Feb 4.

29.

Pro-inflammatory activation following demyelination is required for myelin clearance and oligodendrogenesis.

Cunha MI, Su M, Cantuti-Castelvetri L, Müller SA, Schifferer M, Djannatian M, Alexopoulos I, van der Meer F, Winkler A, van Ham TJ, Schmid B, Lichtenthaler SF, Stadelmann C, Simons M.

J Exp Med. 2020 May 4;217(5). pii: e20191390. doi: 10.1084/jem.20191390.

PMID:
32078678
30.

Baseline and interim PET-based outcome prediction in peripheral T-cell lymphoma: A subgroup analysis of the PETAL trial.

Schmitz C, Rekowski J, Müller SP, Hertenstein B, Franzius C, Ganser A, Bengel FM, Kroschinsky F, Kotzerke J, La Rosée P, Freesmeyer M, Hoeffkes HG, Hertel A, Behringer D, Mesters R, Weckesser M, Mahlmann S, Haberkorn U, Martens U, Prange-Krex G, Brenner W, Giagounidis A, Moeller R, Runde V, Sandmann M, Hautzel H, Wilop S, Krohn T, Dürk H, Heike M, Alashkar F, Brinkmann M, Trenn G, Wacker D, Kreisel-Büstgens C, Bernhard H, Heil G, Larisch R, Kurch L, Jöckel KH, Hoelzer D, Klapper W, Boellaard R, Dührsen U, Hüttmann A.

Hematol Oncol. 2020 Feb 18. doi: 10.1002/hon.2697. [Epub ahead of print]

PMID:
32067259
31.

Neuro-Clinical signatures of language impairments after acute stroke: a VBQ analysis of quantitative native CT scans.

Muller S, Dauyey K, Ruef A, Lorio S, Eskandari A, Schneider L, Beaud V, Roggenhofer E, Draganski B, Michel P, Kherif F.

Curr Top Med Chem. 2020 Feb 10. doi: 10.2174/1568026620666200211113824. [Epub ahead of print]

PMID:
32066362
32.

Shape-controlling effects of hydrohalic and carboxylic acids in TiO2 nanoparticle synthesis.

Sellschopp K, Heckel W, Gäding J, Schröter CJ, Hensel A, Vossmeyer T, Weller H, Müller S, Vonbun-Feldbauer GB.

J Chem Phys. 2020 Feb 14;152(6):064702. doi: 10.1063/1.5138717.

PMID:
32061241
33.

Signal peptide peptidase-like 2c impairs vesicular transport and cleaves SNARE proteins.

Papadopoulou AA, Müller SA, Mentrup T, Shmueli MD, Niemeyer J, Haug-Kröper M, von Blume J, Mayerhofer A, Feederle R, Schröder B, Lichtenthaler SF, Fluhrer R.

EMBO Rep. 2019 Mar;20(3):e46451. doi: 10.15252/embr.201846451. Epub 2019 Feb 7.

34.

Hospital-wide ELectronic medical record evaluated computerised decision support system to improve outcomes of Patients with staphylococcal bloodstream infection (HELP): study protocol for a multicentre stepped-wedge cluster randomised trial.

Hagel S, Gantner J, Spreckelsen C, Fischer C, Ammon D, Saleh K, Phan-Vogtmann LA, Heidel A, Müller S, Helhorn A, Kruse H, Thomas E, Rißner F, Haferkamp S, Vorwerk J, Deffge S, Juzek-Küpper MF, Lippmann N, Lübbert C, Trawinski H, Wendt S, Wendt T, Dürschmid A, Konik M, Moritz S, Tiller D, Röhrig R, Schulte-Coerne J, Fortmann J, Jonas S, Witzke O, Rath PM, Pletz MW, Scherag A.

BMJ Open. 2020 Feb 10;10(2):e033391. doi: 10.1136/bmjopen-2019-033391.

35.

Clonal ZEB1-driven mesenchymal transition promotes targetable oncologic anti-angiogenic therapy resistance.

Chandra A, Jahangiri A, Chen W, Nguyen AT, Yagnik G, Pereira MP, Jain S, Garcia JH, Shah SS, Wadhwa H, Joshi RS, Weiss J, Wolf KJ, Lin JG, Müller S, Rick JW, Diaz AA, Gilbert LA, Kumar S, Aghi MK.

Cancer Res. 2020 Feb 10. pii: canres.1305.2019. doi: 10.1158/0008-5472.CAN-19-1305. [Epub ahead of print]

PMID:
32041837
36.

Role of lymphadenectomy, adjuvant chemotherapy, and treatment at high-volume centers in patients with resected pancreatic cancer-a distinct view on lymph node yield.

Warschkow R, Tsai C, Köhn N, Erdem S, Schmied B, Nussbaum DP, Gloor B, Müller SA, Blazer D 3rd, Worni M.

Langenbecks Arch Surg. 2020 Feb;405(1):43-54. doi: 10.1007/s00423-020-01859-2. Epub 2020 Feb 10.

PMID:
32040705
37.

Converging patterns of aging-associated brain volume loss and tissue microstructure differences.

Taubert M, Roggenhofer E, Melie-Garcia L, Muller S, Lehmann N, Preisig M, Vollenweider P, Marques-Vidal P, Lutti A, Kherif F, Draganski B.

Neurobiol Aging. 2020 Apr;88:108-118. doi: 10.1016/j.neurobiolaging.2020.01.006. Epub 2020 Jan 15.

PMID:
32035845
38.

Simplification of fused deposition modeling 3D-printing paradigm: Feasibility of 1-step direct powder printing for immediate release dosage form production.

Fanous M, Gold S, Muller S, Hirsch S, Ogorka J, Imanidis G.

Int J Pharm. 2020 Mar 30;578:119124. doi: 10.1016/j.ijpharm.2020.119124. Epub 2020 Feb 5.

PMID:
32035253
39.

Gastric bypass surgery in a rat model alters the community structure and functional composition of the intestinal microbiota independently of weight loss.

Haange SB, Jehmlich N, Krügel U, Hintschich C, Wehrmann D, Hankir M, Seyfried F, Froment J, Hübschmann T, Müller S, Wissenbach DK, Kang K, Buettner C, Panagiotou G, Noll M, Rolle-Kampczyk U, Fenske W, von Bergen M.

Microbiome. 2020 Feb 7;8(1):13. doi: 10.1186/s40168-020-0788-1.

40.

Correction of autophagy impairment inhibits pathology in the NOD.H-2h4 mouse model of primary Sjögren's syndrome.

Voynova E, Lefebvre F, Qadri A, Muller S.

J Autoimmun. 2020 Mar;108:102418. doi: 10.1016/j.jaut.2020.102418. Epub 2020 Feb 4.

PMID:
32029330
41.

Secondary Tracheoesophageal Puncture After Laryngectomy Increases Complications With Shunt and Voice Prosthesis.

Scherl C, Kauffels J, Schützenberger A, Döllinger M, Bohr C, Dürr S, Fietkau R, Haderlein M, Koch M, Traxdorf M, Mantsopoulos K, Müller S, Iro H.

Laryngoscope. 2020 Feb 6. doi: 10.1002/lary.28517. [Epub ahead of print]

PMID:
32027385
42.

Metabolic tumor volume, cancer cell fraction, and prognosis - the case of T-cell/histiocyte-rich large B-cell lymphoma.

Schmitz C, Rekowski J, Reinke S, Müller SP, Hüttmann A, Klapper W, Dührsen U.

Leuk Lymphoma. 2020 Feb 5:1-8. doi: 10.1080/10428194.2020.1713319. [Epub ahead of print]

PMID:
32022621
43.

Pulmonary sclerosing pneumocytoma: Cytomorphology and immunoprofile.

Maleki Z, Muller S, Layfield L, Siddiqui MT, Rekhtman N, Pantanowitz L.

Cancer Cytopathol. 2020 Feb 5. doi: 10.1002/cncy.22251. [Epub ahead of print]

PMID:
32022435
44.

A Multi-Modal Person Perception Framework for Socially Interactive Mobile Service Robots.

Müller S, Wengefeld T, Trinh TQ, Aganian D, Eisenbach M, Gross HM.

Sensors (Basel). 2020 Jan 28;20(3). pii: E722. doi: 10.3390/s20030722.

45.

Feasibility and face validity of outcome measures for use in future studies of Polymyalgia Rheumatica (PMR): An OMERACT Study.

Yates M, Owen CE, Muller S, Graham K, Neill L, Twohig H, Boers M, Pujades-Rodriguez M, Goodman S, Cheah J, Dejaco C, Mukhtyar C, Nielsen BD, Robson J, Simon LS, Shea B, Mackie SL, Hill CL; OMERACT PMR Working Group.

J Rheumatol. 2020 Feb 1. pii: jrheum.190575. doi: 10.3899/jrheum.190575. [Epub ahead of print]

PMID:
32007937
46.

Osteogenic potential of heterogeneous and CD271-enriched mesenchymal stromal cells cultured on apatite-wollastonite 3D scaffolds.

Müller S, Nicholson L, Al Harbi N, Mancuso E, Jones E, Dickinson A, Wang XN, Dalgarno K.

BMC Biomed Eng. 2019 Jun 19;1:16. doi: 10.1186/s42490-019-0015-y.

47.

SUMO pathway inhibition targets an aggressive pancreatic cancer subtype.

Biederstädt A, Hassan Z, Schneeweis C, Schick M, Schneider L, Muckenhuber A, Hong Y, Siegers G, Nilsson L, Wirth M, Dantes Z, Steiger K, Schunck K, Langston S, Lenhof HP, Coluccio A, Orben F, Slawska J, Scherger A, Saur D, Müller S, Rad R, Weichert W, Nilsson J, Reichert M, Schneider G, Keller U.

Gut. 2020 Jan 30. pii: gutjnl-2018-317856. doi: 10.1136/gutjnl-2018-317856. [Epub ahead of print]

48.

Contribution of cholinergic system and Nrf2/HO-1 signaling to the anti-amnesic action of 7-fluoro-1,3-diphenylisoquinoline-1-amine in mice.

Müller SG, Pesarico AP, Rosa SG, Martini F, Nogueira CW.

Chem Biol Interact. 2020 Feb 1;317:108959. doi: 10.1016/j.cbi.2020.108959. Epub 2020 Jan 27.

PMID:
32001261
49.

SUMO Chains Rule on Chromatin Occupancy.

Keiten-Schmitz J, Schunck K, Müller S.

Front Cell Dev Biol. 2020 Jan 10;7:343. doi: 10.3389/fcell.2019.00343. eCollection 2019. Review.

50.

Optimizing Workflows for Fast and Reliable Metabolic Tumor Volume Measurements in Diffuse Large B Cell Lymphoma.

Burggraaff CN, Rahman F, Kaßner I, Pieplenbosch S, Barrington SF, Jauw YWS, Zwezerijnen GJC, Müller S, Hoekstra OS, Zijlstra JM, De Vet HCW, Boellaard R; PETRA Consortium.

Mol Imaging Biol. 2020 Jan 28. doi: 10.1007/s11307-020-01474-z. [Epub ahead of print]

PMID:
31993925

Supplemental Content

Loading ...
Support Center